title: Better predictive factors in endocrine-responsive breast cancer than the estrogen receptor itself.
authors.affiliation: Department of Medicine, Medical Oncology Clinic, Jules Bordet Institute, Brussels, Belgium. fatima.cardoso@bordet.be
authors.forename: F
authors.initials: F
authors.lastname: Cardoso
authors.forename: L
authors.initials: L
authors.lastname: Dal Lago
authors.forename: S
authors.initials: S
authors.lastname: Braga
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D020847:Estrogen Receptor Modulators / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000037:antagonists & inhibitors*; D011960:Receptors, Estrogen / Q000378:metabolism*; D011980:Receptors, Progesterone / Q000378:metabolism
chemical_list: D018931:Antineoplastic Agents, Hormonal; D020847:Estrogen Receptor Modulators; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone